Loading organizations...
§ Private Profile · San Francisco, CA, USA
Qualio is a technology company.
Qualio develops cloud-based electronic Quality Management System (eQMS) software, specifically designed for life science organizations. The platform integrates quality management, product lifecycle, and compliance intelligence, offering capabilities such as AI-powered gap analysis and cross-mapping evidence across various regulatory standards. It helps companies digitize documentation, manage design controls, track training, mitigate risks, and streamline audit processes, ensuring continuous readiness and accelerating market access for complex products.
The company was founded in 2012 by Robert Fenton. With a background in pharmacy, Fenton recognized the significant challenges and inefficiencies faced by life science companies in navigating complex regulatory landscapes and maintaining stringent quality standards. This insight led him to establish Qualio, aiming to simplify compliance and quality assurance for a highly regulated industry.
Qualio primarily serves a diverse customer base within the life sciences, including medical device, pharmaceutical, and biotechnology firms. Its overarching vision is to enable these organizations to achieve faster product launches, facilitate smarter scaling, and ensure seamless, continuous compliance. The platform aims to optimize quality and compliance frameworks, positioning its users as best-in-class and market-ready within their respective sectors.
Qualio has raised $61.3M across 3 funding rounds.
Qualio has raised $61.3M in total across 3 funding rounds.
Qualio has raised $61.3M across 3 funding rounds. Most recently, it raised $50.0M Series B in May 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2021 | $50M Series B | John Curtius | Alpine Ventures, Goodwater Capital, Learn Capital, Menlo Ventures, Storm Ventures, Frontline Ventures, Anthology Fund, MHS Capital, Operator Partners, Sorenson Ventures | Announced |
| Jul 1, 2020 | $11M Series A | Storm Ventures | Afore Capital, Basecamp Fund, Canaan Partners, Cedar Capital Group, Convective Capital, Curie.bio, Designer Fund, Founder Collective, Gradient Ventures, Insight Partners, Liquid 2 Ventures, MZ, Operator Partners, Scale Venture Partners, Shine Capital, Soma Capital, Stellar Capital, The Finger Group, Tribe Capital, TWO Sigma Ventures, Worklife Ventures, BEN Porterfield, Larry Gadea, Michael MA, Scott Belsky, William Hockey, Frontline Ventures, MHS Capital, Sorenson Ventures | Announced |
| Apr 1, 2016 | $340K Seed | — | Yamaha Motor Ventures | Announced |
Qualio builds a cloud-based quality management system (QMS) platform tailored for life science organizations, including medical device, pharmaceutical, biotech, and diagnostics companies.[1][2][4][5] It serves over 650 customers worldwide by solving complex regulatory compliance challenges—such as FDA QSR, ISO 13485, GxP, and emerging frameworks like FDA QMSR—through streamlined document control, training, audits, risk management, and AI-powered compliance intelligence, enabling faster market launches and audit readiness in weeks rather than months.[1][2][3][4][5] With reported revenue of $22M and strong growth momentum, including global expansion to nearly 500 customers by 2022 and recent AI enhancements like Compliance Intelligence launched in October 2025, Qualio empowers lean teams to digitize quality processes, integrate with tools like Jira and Salesforce, and maintain continuous compliance without sacrificing speed.[1][3][5]
Founded in 2012 and headquartered in San Francisco, Qualio emerged to address the inefficiencies of paper-based and fragmented quality systems in growing life science firms.[1][4] The company has evolved from a core QMS focused on document control and compliance to a comprehensive Life Sciences GRC (Governance, Risk, and Compliance) platform, incorporating product lifecycle management and AI-driven features.[2][5] Key milestones include tripling its advisory team in 2021 for accelerated go-to-market support, launching Qualio Plus and Qualio Plus Audit services, significant client growth in 2022 (e.g., helping Fifth Eye pass regulatory audits rapidly), and earning recognition as one of Inc.'s Best Workplaces.[3] Operating with a fully remote team, Qualio has scaled to support regulatory lifecycle needs across pharmaceuticals, medtech, and CROs.[1][3]
Qualio stands out in the crowded QMS market through these key strengths:
Qualio rides the digital transformation wave in life sciences, where tightening regulations (e.g., FDA's QMSR shift) and AI adoption demand agile, data-centric compliance amid rising medtech/biopharma innovation.[2][5] Its timing aligns perfectly with post-pandemic supply chain pressures and global expansion needs, enabling SaMD and biotech firms to accelerate launches while navigating evolving standards like ISO 27001 for data security.[1][3][5] Market forces favoring Qualio include the shift from manual/paper systems to integrated GRC platforms, reducing recall risks and audit surprises for resource-strapped startups.[4][6] By fostering collaborative ecosystems with design tools and CROs, Qualio influences the sector toward "quality-first" agility, helping companies like Sentec achieve 360-degree audit views and positioning it as a linchpin for the $100B+ life sciences software market.[5]
Qualio is poised for accelerated growth through its AI-enhanced platform, targeting deeper penetration in biopharma and diagnostics as regulations evolve toward real-time monitoring.[5] Trends like AI-driven predictive compliance, expanded SaMD validation, and global harmonization (e.g., ICH updates) will amplify its edge, potentially doubling revenue via new integrations and enterprise wins.[1][2][3] Its influence may expand by setting standards for lean GRC, empowering more startups to scale compliantly and innovate faster—reinforcing its role as the go-to for life sciences racing to market with quality at the core.[5]
Qualio has raised $61.3M in total across 3 funding rounds.
Qualio's investors include John Curtius, Alpine Ventures, Goodwater Capital, Learn Capital, Menlo Ventures, Storm Ventures, Frontline Ventures, MHS Capital, Operator Partners, Sorenson Ventures, Afore Capital, Basecamp Fund.